Korean Ministry Plan To Order Penalty-based Price Cuts On Pharmaceuticals Faces Resistance From Global And Local Players
This article was originally published in PharmAsia News
Executive Summary
SEOUL - Imminent plans in the works by South Korea's Ministry for Health, Welfare and Family Affairs to cut retail drug prices by up to 20 percent are triggering opposition from both international pharmaceutical firms and local producers of generic products
You may also be interested in...
PharmAsia News' Top Industry Trends Of 2009
As PharmAsia News wraps up its second year of publishing, we look back to some of the top trends and stories of 2009, as well as developing stories to keep an eye on in 2010
PharmAsia News' Top Industry Trends Of 2009
As PharmAsia News wraps up its second year of publishing, we look back to some of the top trends and stories of 2009, as well as developing stories to keep an eye on in 2010
LG Life Science Tops R&D Investment List of Korea-Listed Pharmas
SEOUL - Of the 37 local Korean pharmas listed on Korea's main KOSPI stock market, LG Life Science topped local pharmas in R&D investment last year in both scale and in proportion to its sales, according to a report released by a lawmaker in an Oct. 6 National Assembly session